| 证券代码 | PTHN.N |
| 证券名称 | Patheon NV |
| 证券类型 | 美股 |
| 上市场所 | 纽约证券交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2016-07-21 |
| 首发价格(元) | 21 USD |
| 首发数量(股) | 29761905 |
| 首发募资额(元) | 625,000,005.00 USD |
| 首发主承销商 | J.P. Morgan Securities LLC,Jefferies LLC,Morgan Stanley & Co. LL |
| 货币单位 | USD |
| 公司名称 | Patheon N.V. |
| 注册地址 | 荷兰 |
| 办公地址 | Herengracht 483, Amsterdam, The Netherlands |
| 成立日期 | 2013-12-24 |
| 董事会主席 | Paul S. Levy |
| 公司属地 | Netherlands 荷兰 |
| 公司网址 | www.patheon.com |
| 电话 | +31 (20)-622-3243 |
| 传真 | - |
| 公司简介 | Patheon N.V. is a leading global provider of pharmaceutical development and manufacturing services. With approximately 9,100 employees and contractors worldwide, Patheon provides a comprehensive, integrated and highly customizable set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. |